News

Company News: Curetis Announces New Supervisory Board of Curetis N.V.

Curetis B.V. [1] (“Curetis”), a developer of next-level molecular diagnostic solutions, today announced the composition of its supervisory board. William E. Rhodes, III, will be serving as chairman of Curetis’ supervisory board (the “Board”), while Mario Crovetto will serve as chairman of Curetis’ audit committee. Board members Dr. Werner Schaefer, Dr. Frank Muehlenbeck, Dr. Rudy Dekeyser, and Dr. Holger Reithinger have previously been members of the supervisory board of Curetis AG.

William Rhodes is a healthcare executive with more than 30 years of experience in the healthcare industry, and has been serving as an Operating Partner with Linden Capital Partners´ investment team since January 2013. During his 14-year career at Becton, Dickinson and Company (BD, 1998-2012), Mr. Rhodes was an Executive Officer and held several senior leadership positions, including roles as Worldwide President of BD Biosciences (2009-2011). He was responsible for BD’s corporate M&A activities as well as leading and growing operating companies. Furthermore, he founded BD Ventures, the venture capital arm of Becton, Dickinson and Co. Prior to Becton Dickinson, he held senior business development positions at Johnson & Johnson and Pfizer Inc. Mr. Rhodes also has served, among other roles, as President of The William-James Co. and has a track record of more than 20 successful acquisitions and divestitures. Mr. Rhodes holds a Master’s degree in International Business from Seton Hall University and a BSc degree from Cornell University.

Mario Crovetto has been working as an independent advisor on M&A and corporate projects, notably integrations, divestments and financing since 2011. From 1999 to 2011, he was the CFO of Eurand NV (Specialty Pharmaceuticals), which he took public on NASDAQ in 2007. From 1990 to 1999, he held various senior business positions at Recordati (Pharma-ceuticals), including VP of Corporate Development, Division Manager of Diagnostics and CFO. Prior to that, he worked in various positions at Montedison (Speciality Chemicals), Digital Equipment Corporation, Mobil and SIAR (Management Consulting). Mr. Crovetto holds a BSc in Economics from the Università Cattolica del Sacro Cuore, Milan, and a Master’s degree in Business Economics from Harvard University, Cambridge, MA.

[1] Curetis B.V. will be converted into Curetis N.V.